Evidence map›Paper›PMID 42052413›Full record

ArticleDigital health

The clinician as gatekeeper in the age of "deep research".

Henry Bair, Mak Djulbegovic, David J Taylor Gonzalez

Abstract read
In one paragraph

Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Henry BairWills Eye Hospital, Philadelphia, PA, USA.ORCID https://orcid.org/0000-0002-3422-0373
Mak DjulbegovicWills Eye Hospital, Philadelphia, PA, USA.
David J Taylor GonzalezThe University of Tennessee Health Science Center Department of Ophthalmology, Hamilton Eye Institute, Memphis, TN, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinicians face an ever-increasing volume of medical literature and are turning to large language models and "deep research" systems to retrieve, organize, and synthesize biomedical evidence. In our use of these tools, we have found them useful in producing coherent and comprehensive summaries and proposing testable hypotheses. However, the outputs of these models are prone to flattening evidentiary hierarchies, overgeneralizing across heterogeneous populations and comparators, and occasionally propagating hallucinated citations. These failure modes risk automation bias and erosion of transparency if introduced into clinical pathways without guardrails. Here, we propose a "clinician-in-the-loop" in which clinicians remain the gatekeepers for artificial intelligence-assisted synthesis. We outline three core duties for clinicians: (1) evidence weighting that privileges randomized trials, high-quality meta-analyses, and absolute risk communication; (2) contextual integration across pathophysiology, existing evidence, and patient populations; and (3) provenance and bias auditing through source verification, uncertainty reporting, and counter-summaries. We moreover explore how healthcare institutions, medical educators, policymakers, and publishers of medical literature can promote literacy and transparency regarding the use of "deep research" tools, including the implementation of reporting standards, provenance disclosures, and equity surveillance.

Indexed as

artificial intelligenceautomation biasDeep researchevidence synthesislarge language models

Identifiers

PMID42052413
PMCPMC13111849

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.